P695: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO TREATMENT WITH DNA DEMETHYLATION AGENT

MLA

Ignacio Campillo-Marcos, et al. “P695: Single-Cell Multiomics Analysis of Myelodysplastic Syndrome Predicts Clinical Response to Treatment with Dna Demethylation Agent.” HemaSphere, vol. 7, Aug. 2023, p. e4630768. EBSCOhost, https://doi.org/10.1097/01.HS9.0000969684.46307.68.

APA

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, David Valcarcel, Antonieta Molero, Lurdes Zamora, Laura Palomo, Pamela Acha, Ana Manzanares, Francesc Sole, & Manel Esteller. (2023). P695: Single-Cell Multiomics Analysis of Myelodysplastic Syndrome Predicts Clinical Response to Treatment with Dna Demethylation Agent. HemaSphere, 7, e4630768. https://doi.org/10.1097/01.HS9.0000969684.46307.68

Chicago

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, David Valcarcel, et al. 2023. “P695: Single-Cell Multiomics Analysis of Myelodysplastic Syndrome Predicts Clinical Response to Treatment with Dna Demethylation Agent.” HemaSphere 7 (August): e4630768. doi:10.1097/01.HS9.0000969684.46307.68.